help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibanez, L.
Right arrow Articles by Carrascosa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibanez, L.
Right arrow Articles by Carrascosa, A.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 1237-1243, Copyright © 1996 by Endocrine Society


ARTICLES

Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism

L Ibanez, N Potau, M Zampolli, N Prat, R Virdis, E Vicens-Calvet and A Carrascosa
Hospital Materno-Infantil Vall d'Hebron, Autonomous University, Barcelona, Spain.

Previous studies have documented the association of insulin resistance and hyperandrogenism in adult women with functional ovarian hyperandrogenism (FOH) or polycystic ovary syndrome (a form of FOH). However, the possible impact of adrenal hyperandrogenism development during childhood in premature pubarche (PP) patients on postpubertal insulin secretion patterns remains unclear. The fasting insulin to glucose ratio, C peptide, early insulin response to glucose (IRG), mean blood glucose, mean serum insulin (MSI), glucose uptake rate in peripheral tissues (M), and insulin sensitivity indexes (SI) in response to a standard oral glucose tolerance test were evaluated in 13 PP girls with FOH (group A; age, 17.2 +/- 0.5 yr), 11 eumenorrheic nonhirsute PP girls (group B; age, 16.6 +/- 0.5 yr), and 21 age-matched controls (group C). Body mass indexes (BMI) were similar in the 3 groups (group A, 23.3 +/- 0.8; group B, 22.5 +/- 0.6; group C, 20.6 +/- 0.5 kg/m2). MSI values were significantly higher in FOH patients than in controls (74.7 +/- 17.6 vs. 45.7 +/- 4.1 mU/L; P < 0.01), but were not different from those in group B (63.3 +/- 11.1 mU/L). Thirty-eight percent of FOH patients (group A) and 27% of non-FOH patients (group B), all of whom had normal BMI, showed MSI levels well above the upper normal limit for controls (> 83.3 mU/L). MSI correlated with the degree of ovarian hyperandrogenism [defined by an abnormal 17- hydroxyprogesterone response to challenge with the GnRH analog leuprolide acetate; group A] and with the free androgen index [testosterone (nanomoles per L)/sex hormone-binding globulin (nanomoles per L) x 100; groups A and B)]. Although IRG, glucose uptake rate in peripheral tissues, mean blood glucose, and SI values were not significantly different in the 3 groups, 3 patients in group A and 1 patient in group B showed decreased insulin sensitivity and/or an enhanced early IRG. Among others, significant correlations between MSI and free androgen index values (r = 0.6; P < 0.002; groups A and B) and between BMI and SI (r = -0.53; P < 0.05; groups A and B) were found. Peak 17-hydroxyprogesterone responses to ACTH at PP diagnosis correlated positively with SI in both groups of patients (r = 0.53; P < 0.007). Hyperinsulinemia is a common feature in adolescent PP patients with FOH and appears to be directly related to the degree of androgen excess. Long term follow-up of PP patients into adulthood is warranted to ascertain whether hyperinsulinemia actually precedes FOH development and whether overt insulin resistance ensues.


This article has been cited by other articles:


Home page
Hum ReprodHome page
P. Vigil, P. Contreras, J. L. Alvarado, A. Godoy, A. M. Salgado, and M. E. Cortes
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome
Hum. Reprod., November 1, 2007; 22(11): 2974 - 2980.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Vambergue, C. Lautier, A.S. Valat, C. Cortet-Rudelli, F. Grigorescu, and D. Dewailly
Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report
Hum. Reprod., May 1, 2006; 21(5): 1274 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Chakrabarty, B. T. Miller, T. J. Collins, and M. Nagamani
Ovarian Dysfunction in Peripubertal Hyperinsulinemia
Reproductive Sciences, February 1, 2006; 13(2): 122 - 129.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Endocr. Rev., April 1, 2005; 26(2): 251 - 282.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Carbunaru, P. Prasad, B. Scoccia, P. Shea, N. Hopwood, F. Ziai, Y. T. Chang, S. E. Myers, J. I. Mason, and S. Pang
The Hormonal Phenotype of Nonclassic 3{beta}-Hydroxysteroid Dehydrogenase (HSD3B) Deficiency in Hyperandrogenic Females Is Associated with Insulin-Resistant Polycystic Ovary Syndrome and Is Not a Variant of Inherited HSD3B2 Deficiency
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 783 - 794.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
J. Sheeder, S. H. Travers, and C. Stevens-Simon
Is This Patient Insulin Resistant? How Much Does It Matter?
Clinical Pediatrics, November 1, 2003; 42(9): 835 - 839.
[PDF]


Home page
Endocr. Rev.Home page
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Endocr. Rev., December 1, 2000; 21(6): 671 - 696.
[Abstract] [Full Text]


Home page
PediatricsHome page
A. Pathomvanich, D. P. Merke, and G. P. Chrousos
Early Puberty: A Cautionary Tale
Pediatrics, January 1, 2000; 105(1): 115 - 116.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Adrenal Hyperandrogenism in Children
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4431 - 4435.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Jaquet, J. Leger, D. Chevenne, P. Czernichow, and C. Levy-Marchal
Intrauterine Growth Retardation Predisposes to Insulin Resistance But Not to Hyperandrogenism in Young Women
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3945 - 3949.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ibáñez, F. de Zegher, and N. Potau
Anovulation after Precocious Pubarche: Early Markers and Time Course in Adolescence
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2691 - 2695.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Vuguin, B. Linder, R. G. Rosenfeld, P. Saenger, and J. DiMartino-Nardi
The Roles of Insulin Sensitivity, Insulin-Like Growth Factor I (IGF-I), and IGF-Binding Protein-1 and -3 in the Hyperandrogenism of African-American and Caribbean Hispanic Girls with Premature Adrenarche
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2037 - 2042.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ibáñez, N. Potau, I. Francois, and F. de Zegher
Precocious Pubarche, Hyperinsulinism, and Ovarian Hyperandrogenism in Girls: Relation to Reduced Fetal Growth
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3558 - 3562.
[Abstract] [Full Text]


Home page
PediatricsHome page
S. Banerjee, S. Raghavan, E. J. Wasserman, B. L. Linder, P. Saenger, and J. DiMartino-Nardi
Hormonal Findings in African-American and Caribbean Hispanic Girls With Premature Adrenarche: Implications for Polycystic Ovarian Syndrome
Pediatrics, September 1, 1998; 102(3): e36 - e36.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Dunaif
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Endocr. Rev., December 1, 1997; 18(6): 774 - 800.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ibanez, N. Potau, M. Zampolli, S. RiquE, P. Saenger, and A. Carrascosa
Hyperinsulinemia and Decreased Insulin-Like Growth Factor-Binding Protein-1 Are Common Features in Prepubertal and Pubertal Girls with a History of Premature Pubarche
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2283 - 2288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society